Abortion Drugs Market Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

1. ABORTION DRUGS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Abortion Drugs Market - Overview Abortion Drugs Market, By Drug (Mifepristone and Misoprostol), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027 Abortion is termination of pregnancy, which can be done by using a medicine or surgery to remove the embryo or fetus as well as placenta from the uterus. Furthermore, mifepristone and misoprostol are abortion medicines that are a safe and effective way to terminate pregnancy. Moreover, progesterone hormone helps in normally pregnancy growth so that to block the effect of progesterone hormone, mifepristone abortion medicine is used. When the progesterone hormones are blocked, the lining of uterus breaks down and pregnancy gets terminated. Also, after taking mifepristone, doctor recommends to take second abortion medicine called misoprostol, which causes bleeding and cramping to empty the uterus. If the patient does not have bleeding within 24 hours after taking misoprostol, the patients should consult a doctor. The patient can take abortion medicine up to 70 days (10 week) after the first day of last mensuration. If it has been more than 70 days since the first day of last mensuration, doctor recommends to go for surgery to terminate the pregnancy. Mifepristone is also marketed under the name, Mifeprex, Korlym, and RU486. Browse Research Reports: https://www.coherentmarketinsights.com/ongoing- insight/abortion-drugs-market-3737 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION Global Abortion Drugs Market: Drivers The abortion drugs market is expected to experience significant growth over the forecast period due to increasing abortion cases among women, globally. For instance, according to the Centers for Disease Control and Prevention, 623,471 abortion cases were reported in 2016. According to the same source, rate of abortion was 11.6 per 1,000 individual women who are in the age group of 15 to 44 years in 2016. Furthermore, in 2016, new label for mifepristone medicine was approved by the U.S. Food and Drug Administration (FDA). Moreover, the U.S FDA approval of new label for mifepristone assures safety of medicine for all women. Global Abortion Drugs Market: Restraints However, side effects associated with the mifepristone drug for termination of pregnancy such as fever higher than 100.4 degree for longer than four hours, vomiting, nausea, diarrhea, and severe pelvic pain are major factors that restrain the global abortion drugs market growth. Moreover, high cost associated with the mifepristone drug is another factor hampering the global abortion drugs market growth. For instance, cost of mifepristone drug is US$ 83.33 for every 200mg tablet in the U.S. Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/3737 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Furthermore, on March 24, 2020, Texas announced abortion as non-essential procedure to keep the valuable medical resources for treating COVID-19 patients only. it is mentioned that violators can be fined or jailed. As a result, the demand for abortion medicine is expected to decrease in the U.S. North America is expected to hold the largest market share in the global abortion drugs market, owing to increasing approval of drugs for the termination of pregnancy, which is driving the global abortion drugs market growth. For instance, in April 2019, the U.S Food and Drug Administration (FDA) approved GenBioPro, Inc.’s generic Mifeprex medicine, which is used for the termination of intrauterine pregnancy through 70 days gestation. This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex as well as can be safely substituted for Mifeprex. Global Abortion Drugs Market: Key Players Key players operating in the global abortion drugs market include Corcept Therapeutics Inc., Danco Laboratories LLC, GenBioPro, Inc., Sandoz Inc, Yung Shin Pharmaceutical Industrial Co Ltd, Amneal Pharmaceuticals, Actavis Laboratories Fl Inc., Novel Laboratories Inc., and G.D. Searle, LLC. Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/3737 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved